Print Page  Close Window
Keyword Search
2018 | 2017 | 2016 | 2015 | 2014
02/15/18Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Financial Results on March 1, 2018 
02/05/18Paratek Completes Submission of New Drug Applications to U.S. Food and Drug Administration for Oral and Intravenous Omadacycline for Pneumonia and Skin Infections 
02/01/18Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) 
01/31/18Paratek Pharmaceuticals to Present at LEERINK Partners 7th Annual Global Healthcare Conference 
01/18/18Paratek Announces Pricing of Public Offering of Common Stock 
01/17/18Paratek Announces Public Offering of Common Stock 
01/03/18Paratek Provides Update on Pipeline Progress